Prof. David CH Harris, MD
Professor David Harris is a nephrologist who is internationally recognised for his research on the prevention and management of early and late-stage chronic kidney disease (CKD) and his work on preventing/slowing CKD progression. He is Director of Nephrology & Dialysis in Western Sydney Renal Service, President-elect of the International Society of Nephrology and Past-President of the Asian Pacific Society of Nephrology.
Professor Harris is an international expert in renal dialysis and leader in the field of tubular interstitial disease and CKD. His research has generated important novel observations and advances, including identifying contributors to CKD progression such as tubular hypermetabolism, oxidant damage, proteinuric tubular injury and interstitial inflammation, and highlighting the potential of regulatory cells and DNA vaccination for treating CKD. He co-led the IDEAL trial, a 10-year study assessing early versus late initiation of dialysis for end-stage kidney disease. Considered one of the most influential trials in nephrology, the results have led to major changes in dialysis practice worldwide.
Professor Harris has held numerous executive positions in national and international nephrology organisations, helping advance the governance and structure of nephrological clinical practice, teaching and research around the world.
Professor Harris has contributed to Australian and international nephrology guidelines including CARI and KDIGO. He has received many awards recognising his professional contributions including Kidney Health Australia?s highest scientific honour, the Kincaid-Smith Medal (2012) for outstanding clinical and scientific achievement in research into treatment of diseases of the kidney and urinary tract, and the SMS Distinguished Professorial Award, 2016.